Skip to Main Content

Paper Details

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.
EClinicalMedicine
47
2021
COVID-19, HLA, HLA alleles, HLA class I alleles, HLA-C, HLA-C*04:01, HLAs, Human, Human leukocyte antigen alleles, SARS, SARS-, SARS-CoV, SARS-CoV-2, bindings sites, coronavirus 2, coronavirus disease 2019, patients, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Manuel HoltgreweBerlin Institute of Health at Charite - Universitatsmedizin Berlin
Ulrike Kr??gerBerlin Institute of Health at Charite - Universitatsmedizin Berlin
Carolyn S CalfeeUniversity of California san francisco
Tomasz ZemojtelBerlin Institute of Health at Charite - Universitatsmedizin Berlin
Stephan RipkeCharite Universitaetsmedizin Berlin
Stephan RipkeMassachusetts General Hospital
Stephan RipkeStanley Center for Psychiatry Research, Broad Institute of MIT and Harvard Cambridge MA 02142
Stephan RipkeCharite Universitaetsmedizin Berlin
Stephan RipkeMassachusetts General Hospital
Stephan RipkeStanley Center for Psychiatry Research, Broad Institute of MIT and Harvard Cambridge MA 02142
  • 1 - 10

Datasets

Release 1.2